News
AstraZeneca’s Evusheld not recommended for certain adults
The National Institute for Health and Care Excellence (NICE) has issued draft guidance which fails to recommend AstraZeneca’s tixagevimab-cilgavimab – also known as Evusheld – for the prevention of COVID-19.